nifedipine has been researched along with indocyanine green in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ebihara, A; Hosoda, S; Kumagai, Y; Ohashi, K; Sakamoto, K; Sudo, T; Sugimoto, K; Tateishi, T; Toyo-oka, T; Toyosaki, N | 1 |
| Henschel, L; Hoffmann, A; Sigusch, H | 1 |
| Breimer, DD; Kroon, JM; Soons, PA | 1 |
| Fujimura, A; Hosoda, S; Kumagai, Y; Ohashi, K; Sakamoto, K; Sudo, T; Sugimoto, K; Tateishi, T; Toyo-oka, T; Toyosaki, N | 1 |
| Bauer, LA; Horn, JR; Murray, K; Olsen, J; Opheim, K | 1 |
| Blauw, GJ; Breimer, DD; Danhof, M; Ooms, P; van Brummelen, P; van Harten, J | 1 |
| Chang, TT; Chiang, BN; Kong, CW; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Yang, CM | 1 |
| Breimer, DD; Danhof, M; van Brummelen, P; van Harten, J; Zeegers, RR | 1 |
| Challenor, VF; George, CF; Gruchy, BS; Renwick, AG; Waller, DG | 1 |
| Bauer, LA; Davis, R; Greene, L; Horn, JR; Opheim, K; Stenwall, M | 1 |
| Feely, J | 1 |
| Breimer, DD; Cohen, AF; De Boer, A; Kasper, FJ; Kluft, C; Kroon, JM; Schoemaker, HC; Soons, PA | 1 |
| Burggraaf, J; Cohen, AF; Kroon, JM; Schoemaker, RC | 1 |
| Liu, H; Lu, J; Ma, L; Zhang, L; Zhou, H | 1 |
1 review(s) available for nifedipine and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for nifedipine and indocyanine green
| Article | Year |
|---|---|
Effects of diltiazem on the pharmacokinetics of nifedipine.
Topics: Adult; Blood Pressure; Diltiazem; Drug Interactions; Half-Life; Heart Rate; Humans; Indocyanine Green; Kinetics; Male; Nifedipine | 1990 |
Dose dependent effect of diltiazem on the pharmacokinetics of nifedipine.
Topics: Adult; Chromatography, Gas; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Humans; Indocyanine Green; Male; Nifedipine; Pyridines | 1989 |
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
Topics: Adult; Antipyrine; Benzazepines; Biological Availability; Diltiazem; Drug Interactions; Female; Humans; Indocyanine Green; Kinetics; Liver; Male; Metabolic Clearance Rate; Nifedipine; Random Allocation; Verapamil | 1986 |
Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.
Topics: Adult; Blood Pressure; Double-Blind Method; Drug Interactions; Heart Rate; Humans; Indocyanine Green; Kinetics; Liver Circulation; Male; Nifedipine; Recombinant Proteins; Tissue Plasminogen Activator | 1993 |
The influence of nifedipine and captopril on liver blood flow in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Calcium Channel Blockers; Captopril; Coloring Agents; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Liver Circulation; Male; Metabolic Clearance Rate; Nifedipine | 1998 |
10 other study(ies) available for nifedipine and indocyanine green
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].
Topics: Adult; Biotransformation; Caffeine; Debrisoquin; Dipyrone; Humans; Indocyanine Green; Liver; Liver Circulation; Male; Nifedipine; Sulfamethazine; Verapamil | 1991 |
Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Drug Administration Schedule; Half-Life; Humans; Indocyanine Green; Liver; Male; Metabolic Clearance Rate; Nifedipine; Regional Blood Flow; Spectrophotometry; Time Factors | 1990 |
Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
Topics: Administration, Oral; Adult; Blood Pressure; Drug Interactions; Female; Half-Life; Heart Rate; Humans; Indocyanine Green; Injections, Intravenous; Male; Nifedipine; Propranolol | 1989 |
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.
Topics: Administration, Oral; Adult; Blood Specimen Collection; Calcium Channel Blockers; Hemodynamics; Humans; Indocyanine Green; Injections, Intravenous; Liver Circulation; Male; Nifedipine; Nisoldipine; Sotalol | 1989 |
The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Topics: Aged; Ascites; Female; Hepatitis B Surface Antigens; Humans; Indocyanine Green; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nifedipine; Verapamil | 1988 |
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
Topics: Adsorption; Adult; Female; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Liver Circulation; Male; Nifedipine; Nisoldipine; Vasodilator Agents | 1988 |
The trans-hepatic extraction of nifedipine.
Topics: Adult; Aged; Humans; Indocyanine Green; Injections, Intravenous; Liver; Male; Middle Aged; Myocardial Contraction; Nifedipine | 1987 |
Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.
Topics: Adult; Blood Pressure; Female; Humans; Indocyanine Green; Liver; Male; Nifedipine; Nitroglycerin; Pulse; Vasodilation | 1984 |
Corkscrew retinal vessels and retinal arterial macroaneurysm in a patient with neurofibromatosis type 1: A case report.
Topics: Aged; Aneurysm; Angiography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Neurofibromatosis 1; Nifedipine; Retinal Artery; Retinal Vein; Treatment Outcome; Vasodilator Agents; Vision Disorders; Visual Acuity | 2018 |